A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S‐1 plus intravenous paclitaxel for serosa‐positive gastric cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|8|1041-1046

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.8, 2015-06, pp. : 1041-1046

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S‐1 for treatment of gastric cancer with macroscopic peritoneal metastasis

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3354-3358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)]

By  

Oncology, Vol. 78, Iss. 5-6, 2010-07 ,pp. : 302-308

Karger

Access to resources Recommend Favorite

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 311-314

Karger

Access to resources Recommend Favorite

Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 40-46

Karger

Access to resources Recommend Favorite